Cancer
Researchers from the University of Tsukuba have made a significant breakthrough in the treatment of gallbladder cancer, showcasing the potential of a combination therapy approach. The study, published in Cancer Gene Therapy, demonstrates that the efficacy of a replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (GCV) therapy can
Cancer
Cigarette smoke condensate has been shown to transform human breast epithelial cells by upregulating the anti-apoptotic gene bcl-xl, thereby impeding the apoptotic pathway and allowing the accumulation of DNA damage that can lead to cell transformation and carcinogenesis. Researchers have now identified the mechanism by which cigarette smoke condensate upregulates
Cancer
New research on the targeted treatment of glioblastomas, a devastating form of cancer, has shown promising results. Scientists have successfully engineered an oncolytic adenovirus that targets the Delta-EGFR receptor, which is commonly expressed in glioblastoma cells. The virus, called Delta-24-RIVER, was designed to selectively infect and kill cancer cells while
Cancer
Cancer remains a leading cause of death worldwide, with many common cancers such as lung, pancreas, and stomach cancers showing little improvement in treatment despite the introduction of new drugs. Researchers in Tel Aviv, Israel, highlighted the need to develop therapies that promote the innate immune system's ability
Cancer
Researchers at the University of Milan have made new findings on the potential of green tea catechins in preventing cancer. Their study, published in the Journal of Enzyme Inhibition and Medicinal Chemistry, provides a molecular docking investigation into the interaction between green tea catechins and glutathione S-transferase (GST P1-1). The
Cancer
A new study published in Biochemical Pharmacology has shed light on the potential of targeting the RET gene for thyroid cancer therapy. According to the study, activating mutations of the RET gene have been identified as driving oncogenic events in subsets of papillary and medullary thyroid carcinomas. The study'
Cancer
Recent research has identified a synergistic relationship between the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway and Bcl-xL in controlling apoptosis in adenocarcinoma cells of the lung. The study, published in Molecular Cancer Therapeutics, found that inhibition of the PI3K/Akt pathway was more effective in inducing apoptosis when combined with
Cancer
Researchers at Sichuan University have discovered that the matrix protein of vesicular stomatitis virus (VSV) can induce remarkable apoptosis of cancer cells and initiate an immune response, leading to an extraordinary antitumor effect. This study provides promising results for the development of a novel cancer gene therapy agent. The researchers
Cancer
Prostate cancer, particularly androgen-independent (AI) forms, poses a significant challenge in treatment. Researchers have been exploring alternative therapeutic approaches, including enzyme pro-drug suicide gene therapy. A recent study published in Cancer Gene Therapy by Ahn and colleagues from Indiana University, Medical Department, presents a promising solution. The scientists developed AdIU1,
Cancer
Despite significant advances in cancer treatment, the 5-year survival rate for patients with distant metastases of melanoma remains less than 10%. Patients with advanced melanoma often receive systemic therapy, with single-agent cytotoxic chemotherapy using dacarbazine as the standard of care in community practice. However, the response rate is generally low,
Cancer
Scientists in Tokyo, Japan, have made a groundbreaking discovery in the field of cancer research, identifying a potential molecular target for the diagnosis, treatment, and prevention of lung and esophageal carcinomas. By analyzing gene expression profiles of 101 lung cancers and 19 esophageal squamous cell carcinomas, researchers isolated the epithelial
Cancer research
Scientists at Catholic University have reported promising results from a Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer. The study aimed to estimate the maximum-tolerated dose (MTD) of docetaxel and determine the recommended dose (RD) for further studies.
